Skip to main content

Advertisement

Log in

Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

 

A nonradioactive multi-parameter flow cytometry assay was developed to identify antigen-specific lymphocytes in human subjects previously vaccinated against rabies virus and was subsequently compared to the standard tritiated thymidine method. A cell tracking dye, carboxyfluorescein succinimidyl ester, was used in combination with surface label for CD4 and CD8 cells in order to determine the response of lymphocytes to killed rabies virus in an antigen recall assay. The rabies virus-specific lymphocyte response was compared to the humoral immune response in each of ten vaccinated and five non-vaccinated subjects. Lymphocyte responses to rabies virus were observed in all ten vaccinated subjects; some noted as early as 3 days after stimulation while others were not until 7 days after stimulation. There was good agreement between the proliferation index of the CFSE assay and the simulation index of the [3H]thymidine assay (kappa statistic=0.73). An inverse relationship was detected between the level of rabies virus neutralizing antibody (RVNA) and the lymphocyte response to inactivated rabies virus in the vaccinated subjects. The association between cytokines production and level of humoral and cellular response was investigated in four representative subjects. Two vaccinated subjects with high proliferation indices and low RVNA titers produced Th1 type cytokines to rabies virus stimulation, whereas two vaccinated individuals with low proliferation indices and high RVNA titers responses did not produce these cytokines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. Haupt W: Rabies–Risk of exposure and current trends in prevention of human cases. Vaccine 17:1742–1749, 1999

    Article  PubMed  CAS  Google Scholar 

  2. Dietzschold B, Morimoto K, Hooper DC: Mechanisms of virus-induced neuronal damage and the clearance of viruses from the CNS. Curr Top Microbiol Immunol 253:145–155, 2001

    PubMed  CAS  Google Scholar 

  3. Hooper DC, Sauder C, Scott GS, Dietzschold B, Richt JA: Immunopathology and immunoprotection in CNS virus infections: Mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 265:163–182, 2002

    PubMed  CAS  Google Scholar 

  4. Kuwert EK, Barsenbach J, Werner J, Marcus I, Scheiermann N, Grosse-Wilde H et al.: Early/high and late/low responders among HDCS vaccinees. In Cell Culture Rabies Vaccines and Their Protective Effect in Man, EK Kuwert, RJ Wiktor, H Koprowski (eds). Geneva, International Green Cross, 1981, pp 160–168

    Google Scholar 

  5. Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A: Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 18:2661–2667, 2000

    Article  PubMed  CAS  Google Scholar 

  6. Aubert MF: Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735–760, 1992

    PubMed  CAS  Google Scholar 

  7. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711–3719, 1998

    PubMed  CAS  Google Scholar 

  8. Garenne M, Lafon M: Sexist diseases. Perspect Biol Med 41:176–189, 1998

    PubMed  CAS  Google Scholar 

  9. Lafon M: Immunology. In Rabies, AC Jackson, WH Wunner (eds). San Diego, CA, Academic Press, 2002, pp 351–371

  10. Hooper DC: The role of immune responses in the pathogenesis of rabies. J Neurovirol 11:88–92, 2005

    Article  PubMed  CAS  Google Scholar 

  11. Thraenhart O, Kreuzfelder E, Hillebrandt M, Marcus I, Ramakrishnan K, Fu ZF, et al.: Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 71:287–292, 1994

    Article  PubMed  CAS  Google Scholar 

  12. Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M: T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 85:224–230, 1991

    Article  PubMed  CAS  Google Scholar 

  13. Fulcher D, Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77:559–564, 1999

    Article  PubMed  CAS  Google Scholar 

  14. Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK: A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99–112, 1999

    Article  PubMed  CAS  Google Scholar 

  15. Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48:535–541, 1973

    PubMed  CAS  Google Scholar 

  16. Habel K: Habel test for potency. In Laboratory Techniques in Rabies, FX Meslin, MM Kaplan, H Koprowski (eds). Geneva, World Health Organization, 1996, pp 369-373

    Google Scholar 

  17. Centers for Disease Control and Prevention: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 48: 1–21. United States, Morbidity and Mortality Weekly Report, 1999

  18. World Health Organization: World Health Organization Expert Committee on Rabies: Eighth Report. 824. Geneva, WHO Press, WHO Technical Report Series, 1992

  19. Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991

    Google Scholar 

  20. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al.: Memory T cells and vaccines. Vaccine 21:419–430, 2003

    Article  PubMed  CAS  Google Scholar 

  21. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D et al.: Evidence for a viral superantigen in humans. Nature 358:507–510, 1992

    Article  PubMed  CAS  Google Scholar 

  22. Wells AD, Gudmundsdottir H, Turka LA: Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183, 1997

    Article  PubMed  CAS  Google Scholar 

  23. Maino VC: Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry. Vet Immunol Immunopathol 63:199–207, 1998

    Article  PubMed  CAS  Google Scholar 

  24. Lagrelius M, Jones P, Franck K, Gaines H: Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33:156–165, 2006

    Article  PubMed  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

We would like to thank the rabies vaccinated and non-vaccinated individuals who participated in this study. We are indebted to Tammy Koopman and Mehrdad Ameri for their technical assistance and review of the manuscript and to Teri Ricke for her help with the RFFIT testing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan M. Moore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moore, S.M., Wilkerson, M.J., Davis, R.D. et al. Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees. J Clin Immunol 26, 533–545 (2006). https://doi.org/10.1007/s10875-006-9044-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-006-9044-0

KEY WORDS

Navigation